ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream from transcription start sites at the majority of CpG island promoters
Suhn K. Rhie(LAC+USC Medical Center), Peggy Farnham(University of Southern California)
Cited by 90
Related Papers
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
|Cell|1992|840
KAP1 Protein: An Enigmatic Master Regulator of the Genome
|Journal of Biological Chemistry|2011|381
Transcriptome and epigenome landscape of human cortical development modeled in organoids
|Science|2018|314
Suz12 binds to silenced regions of the genome in a cell-type-specific manner
|Genome Research|2006|312